About Menarini Group
Menarini Group is a company based in Florence (Italy). It operates as a Direct-to-Consumer (D2C) and Professional Services. Menarini Group has completed 3 acquisitions, including Orbactiv, Silicon Biosystems and Stemline Therapeutics. Menarini Group offers products and services including Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine. Menarini Group operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Florence, Italy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name A. Menarini Industrie Farmaceutiche Riunite Srl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Orbactiv
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Menarini Group
Menarini Group offers a comprehensive portfolio of products and services, including Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine.
Medicines are developed for various therapeutic areas.
Products are offered for everyday health needs.
Therapies are provided for cancer patient care.
Solutions are created for professional diagnostic needs.
Products are designed for skin and aesthetics.
People of Menarini Group
Unlock access to complete
Unlock access to complete
Funding Insights of Menarini Group
Detailed funding history for Menarini Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Menarini Group
Menarini Group has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Orbactiv, Silicon Biosystems and Stemline Therapeutics.
Investment portfolio details for Menarini Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of a single-dose antibiotic for bacterial skin infections. This antibiotic offers an alternative treatment for acute bacterial skin and skin structure infections caused by specific gram-positive microorganisms. It provides a single-dose option compared to multiple-dose regimens, and the company offers support programs for insurance verification, billing, and patient assistance. The product has three mechanisms of action and is indicated for adult patients. Important safety information includes potential interactions with anticoagulants and the need for monitoring of certain coagulation tests. Adverse reactions are documented in the full prescribing information.
|
Locked | Locked | 2014 | Locked | |
|
Novel oncology therapeutics targeting cancer stem cells are developed.
|
Locked | Locked | 2003 | Locked | |
|
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Menarini Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Menarini Group
Detailed financials for Menarini Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Menarini Group Comparisons
Peer comparison for Menarini Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Menarini Group
Menarini Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Menarini Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Menarini Group
Complete news archive for Menarini Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Menarini Group
Menarini Group is headquartered in Florence, Italy.
Menarini Group is involved in the development and distribution of pharmaceutical products across various therapeutic areas, including oncology, cardiometabolic, and respiratory health. The company is also active in consumer healthcare, diagnostics, and dermatology. Research and innovation are prioritized to address serious health conditions. With a global presence, strategic partnerships are established to enhance product reach and impact. Sustainability and social responsibility are integrated into operations to support communities and environmental initiatives.
Menarini Group's top competitors include Merck, Roivant Sciences and AbbVie.
Menarini Group offers Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine.
Menarini Group has made 3 acquisitions, including Orbactiv, Silicon Biosystems, and Stemline Therapeutics.